Harwood Feffer LLP Announces Investigation of Alere Inc.

Feb 03, 2016, 15:06 ET from Harwood Feffer LLP

NEW YORK, Feb. 3, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Alere Inc. ("Alere" or the "Company") (NYSE: ALR) concerning the proposed acquisition of the Company by Abbott Laboratories ("Abbott").

Under the terms of the offer, Abbott would acquire Alere in a transaction valued at approximately $5.8 billion. Pursuant to the deal, Alere stockholders would receive $56 in cash per share owned. According to Yahoo Finance, at least one analyst has set a target price for Alere stock of $60.00    

Our investigation concerns whether the Alere board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company stockholders. 

If you own Alere shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin I. Sachs-Michaels, Esq. Robert I. Harwood, Esq. Harwood Feffer LLP 488 Madison Avenue New York, New York 10022 Phone Numbers: (877) 935-7400 (212)935-7400 Email: bsachsmichaels@hfesq.com  Website: http://www.hfesq.com  Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO


SOURCE Harwood Feffer LLP